Persistent ocular tremors appear to be associated with Parkinson's disease

April 9, 2012 in Parkinson's & Movement disorders

Persistent ocular tremors that prevent eye stability during fixation appear to be common among patients with Parkinson disease (PD) suggesting that precise oculomotor testing could provide an early physiological biomarker for diagnosing PD, according to a report published Online First by Archives of Neurology.

"Although a number of studies describe various oculomotor abnormalities in subjects with PD, conflicts about the specific deficits remain," writes George T. Gitchel, M.S., of the Southeast Parkinson's Disease Research, Education, and Clinical Center, Hunter Holmes McGuire Veterans Affairs Center, Richmond, Va., and colleagues.

The authors compared oculomotor function between 112 with Parkinson disease and 60 age-matched controls during fixation and while tracking a randomly displaced target on a PC monitor.

"The major finding of the present study was that using modern eye movement tracking, oscillatory fixation instability was universally seen in a large cohort of 112 patients with PD," the authors write. "The fact that this behavior was universally observed in every tested patient with PD, including unmedicated patients, suggests that ocular tremor is a function of the disease process and not induced by medication."

The authors found that all 112 patients with PD showed persistent ocular instability while fixating on a target, compared with only two of the 60 control patients. Additionally, the authors found no differences in oculomotor parameters between medicated and unmedicated patients with PD.

"All patients with PD exhibited persistent ocular tremor that prevented stability during fixation," the authors conclude. "The pervasiveness and specificity of this feature suggest that modern, precise oculomotor testing could provide a valuable early physiological for diagnosing PD."

More information: Arch Neurol. Published online April 9, 2012. doi:10.1001/archneurol.2012.70

Provided by JAMA and Archives Journals search and more info website

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

New animal model gives insights into mechanisms of Parkinson's disease pathogenesis

In Parkinson's disease, the protein "alpha-synuclein" aggregates and accumulates within neurons. Specific areas of the brain become progressively affected as the disease develops and advances. The mechanism underlying this ...

Parkinson's & Movement disorders created 22 hours ago | popularity not rated yet | comments 0

Defective cellular waste removal explains why Gaucher patients often develop Parkinson's disease

Gaucher disease causes debilitating and sometimes fatal neurodegeneration in early childhood. Recent studies have uncovered a link between the mutations responsible for Gaucher disease and an increased risk ...

Parkinson's & Movement disorders created May 23, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Diabetes drug tested in Parkinson's disease patients

Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the ...

Parkinson's & Movement disorders created May 20, 2013 | popularity not rated yet | comments 0

Faulty energy production in brain cells leads to disorders ranging from Parkinson's to intellectual disability

Neuroscientist Patrik Verstreken of VIB (Flanders Institute for Biotechnology) and KU Leuven has shown for the first time that dysfunctional mitochondria in brain cells can lead to learning disabilities. The link between ...

Parkinson's & Movement disorders created May 17, 2013 | popularity 4 / 5 (2) | comments 0

Unleashing the watchdog protein

McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson's disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The ...

Parkinson's & Movement disorders created May 09, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Hormone levels may provide key to understanding psychological disorders in women

Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...